CGS 15873A
Alternative Names: CGS 15873Latest Information Update: 05 Feb 1997
At a glance
- Originator Novartis
- Class Antipsychotics
- Mechanism of Action Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 05 Feb 1997 No-Development-Reported for Parkinson's disease in USA (Unknown route)
- 05 Feb 1997 No-Development-Reported for Psychotic disorders in USA (PO)